---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-26-000712"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2026-01-29T23:59:59+00:00"
generated_at: "2026-05-16T06:19:10.990139+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv FY2025 revenue $9.0M (down ~5% YoY), net loss $0.1M; declares $0.075 special dividend

## Summary
- Revenue $9.0M, decrease of $0.5M YoY; net loss $0.1M, improvement of $0.7M from prior year.
- Special dividend of $0.075 per share approved; payable March 20, 2026 to holders of record Feb 27, 2026.
- CEO cites portfolio rationalization, cost streamlining, and focus on Latin America and Europe for 2026.
- Company traded on OTCQB under ticker PBSV; no explicit guidance provided.

## SEC filing metadata
- accession: 0001654954-26-000712
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2026-01-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495426000712/0001654954-26-000712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495426000712/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-26-000712
- JSON: https://secwatch.observer/filing/0001654954-26-000712.json
- Plain text: https://secwatch.observer/filing/0001654954-26-000712.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.